Beyond signal functions in global obstetric care: Using a clinical cascade to measure emergency obstetric readiness

PloS One
John N CranmerDilys Walker

Abstract

Globally, the rate of reduction in delivery-associated maternal and perinatal mortality has been slow compared to improvements in post-delivery mortality in children under five. Improving clinical readiness for basic obstetric emergencies is crucial for reducing facility-based maternal deaths. Emergency readiness is commonly assessed using tracers derived from the maternal signal functions model. We compare emergency readiness using the signal functions model and a novel clinical cascade. The cascades model readiness as the proportion of facilities with resources to identify the emergency (stage 1), treat it (stage 2) and monitor-modify therapy (stage 3). Data were collected from 44 Kenyan clinics as part of an implementation trial. Although most facilities (77.0%) stock maternal signal function tracer drugs, far fewer have resources to practically identify and treat emergencies. In hypertensive emergencies for example, 38.6% of facilities have resources to identify the emergency (Stage 1 readiness, including sphygmomanometer, stethoscope, urine collection device, protein test). 6.8% have the resources to treat the emergency (Stage 2, consumables (IV Kit, fluids), durable goods (IV pole) and drugs (magnesium sulfate and hydrala...Continue Reading

References

Nov 15, 1991·American Journal of Epidemiology·K M FlegalF J Nieto
Jul 30, 1999·British Journal of Obstetrics and Gynaecology·J Penny
Aug 18, 2004·Health Policy and Planning·Christopher Potter, Richard Brough
Apr 26, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Z GillJ B Smith
Jul 26, 2005·Health Policy·Julia Hussein, Susan Clapham
Feb 28, 2006·Cadernos de saúde pública·João Paulo SouzaSuzanne Jacob Serruya
May 12, 2006·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P BaileyD Fry
Oct 3, 2006·Lancet·Carine RonsmansUNKNOWN Lancet Maternal Survival Series steering group
Nov 1, 2006·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A PaxtonS Lobis
Sep 11, 2008·Paediatric and Perinatal Epidemiology·Joy E LawnSimon Cousens
May 15, 2010·Lancet·Robert E BlackUNKNOWN Child Health Epidemiology Reference Group of WHO and UNICEF
Jun 25, 2010·PLoS Medicine·Mary V KinneyEva Weissman
Nov 26, 2010·Seminars in Perinatology·Joy E LawnSimon Cousens
Mar 4, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edward M GardnerWilliam J Burman
May 15, 2012·Lancet·Li LiuUNKNOWN Child Health Epidemiology Reference Group of WHO and UNICEF
Sep 7, 2012·PloS One·Joao Paulo SouzaUNKNOWN Brazilian Network for Surveillance of Severe Maternal Morbidity
May 15, 2013·PLoS Medicine·Allisyn C MoranJoy E Lawn
Oct 1, 2013·The Lancet Infectious Diseases·Bohdan NosykUNKNOWN STOP HIV/AIDS Study Group
Dec 19, 2013·Bulletin of the World Health Organization·Kathryn O'NeillTies Boerma
May 21, 2014·PloS One·Benjamin P LinasBruce R Schackman
Aug 12, 2014·The Lancet Global Health·Lale SayLeontine Alkema
Sep 2, 2014·Expert Review of Anti-infective Therapy·Elisa MountainMarie-Claude Boily
Jan 28, 2015·Lancet·Nicholas J KassebaumRafael Lozano
Jul 21, 2015·Tropical Medicine & International Health : TM & IH·Filipe Emanuel Fonseca MenezesRicardo Queiroz Gurgel
Sep 10, 2015·Current Opinion in HIV and AIDS·Frank TanserAdrian Dobra

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collection

Software Mentioned

STATA
RedCap

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

© 2022 Meta ULC. All rights reserved